Literature DB >> 1905454

Functional respiratory chain studies in mitochondrial cytopathies. Support for mitochondrial DNA heteroplasmy in myoclonus epilepsy and ragged red fibers (MERRF) syndrome.

E Byrne1, I Trounce, S Marzuki, X Dennett, S F Berkovic, S Davis, M Tanaka, T Ozawa.   

Abstract

Mitochondrial respiratory chain function was investigated with polarographic and enzymatic studies, and correlated with immunoblot studies using a battery of probes against respiratory chain holocomplexes in a series of patients with myoclonus epilepsy and ragged red fibers (MERRF) syndrome. State III respiration rates in intact skeletal muscle mitochondria were normal in two cases, suggested site I deficiency in one case and a mid-respiratory defect in another. Immunological studies of complex I showed reduced levels of several subunits with the apparent absence of two bands (which at 45 and 42 kDa, coincide with the predicted electrophoretic mobility of the ND5 gene product) in one case. Complex I, III and IV composition was normal in the other three cases indicating no major disruption of complex assembly. A differing severity of skeletal muscle respiratory chain impairment in a group of unrelated patients with severe cerebral clinical involvement is best explained by uneven tissue distribution between brain and muscle of a heteroplasmic mtDNA mutation. The relationship between MERRF and mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes (MELAS) encephalopathies is reappraised by extension of this hypothesis.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1905454     DOI: 10.1007/bf00305874

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  30 in total

1.  Partial cytochrome oxidase (aa3) deficiency in chronic progressive external ophthalmoplegia. Histochemical and biochemical studies.

Authors:  E Byrne; X Dennett; I Trounce; R Henderson
Journal:  J Neurol Sci       Date:  1985-12       Impact factor: 3.181

2.  Familial mitochondrial encephalomyopathy (MERRF): genetic, pathophysiological, and biochemical characterization of a mitochondrial DNA disease.

Authors:  D C Wallace; X X Zheng; M T Lott; J M Shoffner; J A Hodge; R I Kelley; C M Epstein; L C Hopkins
Journal:  Cell       Date:  1988-11-18       Impact factor: 41.582

3.  Sequence and organization of the human mitochondrial genome.

Authors:  S Anderson; A T Bankier; B G Barrell; M H de Bruijn; A R Coulson; J Drouin; I C Eperon; D P Nierlich; B A Roe; F Sanger; P H Schreier; A J Smith; R Staden; I G Young
Journal:  Nature       Date:  1981-04-09       Impact factor: 49.962

4.  A mitochondrial encephalomyopathy with cardiomyopathy. A case revealing a defect of complex I in the respiratory chain.

Authors:  M Nishizawa; K Tanaka; K Shinozawa; T Kuwabara; T Atsumi; T Miyatake; E Ohama
Journal:  J Neurol Sci       Date:  1987-04       Impact factor: 3.181

5.  The cerebral metabolism of glucose and oxygen measured with positron tomography in patients with mitochondrial diseases.

Authors:  R S Frackowiak; S Herold; R K Petty; J A Morgan-Hughes
Journal:  Brain       Date:  1988-10       Impact factor: 13.501

6.  Phosphorus magnetic resonance spectroscopy of patients with mitochondrial cytopathies demonstrates decreased levels of brain phosphocreatine.

Authors:  S M Eleff; P B Barker; S J Blackband; J C Chatham; N W Lutz; D R Johns; R N Bryan
Journal:  Ann Neurol       Date:  1990-06       Impact factor: 10.422

7.  Findings in muscle in complex I (NADH coenzyme Q reductase) deficiency.

Authors:  Y Koga; I Nonaka; M Kobayashi; M Tojyo; K Nihei
Journal:  Ann Neurol       Date:  1988-12       Impact factor: 10.422

8.  Progression from MERRF to MELAS phenotype in a patient with combined respiratory complex I and IV deficiencies.

Authors:  E Byrne; I Trounce; X Dennett; B Gilligan; J B Morley; S Marzuki
Journal:  J Neurol Sci       Date:  1988-12       Impact factor: 3.181

9.  Mitochondrial myoneuropathy with respiratory failure and myoclonic epilepsy. A case report with biochemical studies.

Authors:  E Byrne; X Dennett; I Trounce; J Burdon
Journal:  J Neurol Sci       Date:  1985-12       Impact factor: 3.181

10.  Mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes (MELAS): adolescent onset with severe cerebral edema.

Authors:  R A Danks; M Dorevitch; J T Cummins; E Byrne
Journal:  Aust N Z J Med       Date:  1988-02
View more
  5 in total

1.  Normal variants of human mitochondrial DNA and translation products: the building of a reference data base.

Authors:  S Marzuki; A S Noer; P Lertrit; D Thyagarajan; R Kapsa; P Utthanaphol; E Byrne
Journal:  Hum Genet       Date:  1991-12       Impact factor: 4.132

2.  A tRNA(Lys) mutation in the mtDNA is the causal genetic lesion underlying myoclonic epilepsy and ragged-red fiber (MERRF) syndrome.

Authors:  A S Noer; H Sudoyo; P Lertrit; D Thyagarajan; P Utthanaphol; R Kapsa; E Byrne; S Marzuki
Journal:  Am J Hum Genet       Date:  1991-10       Impact factor: 11.025

3.  Tissue segregation of a heteroplasmic mtDNA mutation in MERRF (myoclonic epilepsy with ragged red fibers) encephalomyopathy.

Authors:  P Lertrit; A S Noer; E Byrne; S Marzuki
Journal:  Hum Genet       Date:  1992-11       Impact factor: 4.132

Review 4.  Mitochondrial disease: mutations and mechanisms.

Authors:  Matthew McKenzie; Danae Liolitsa; Michael G Hanna
Journal:  Neurochem Res       Date:  2004-03       Impact factor: 3.996

5.  Habitual physical activity in mitochondrial disease.

Authors:  Shehnaz Apabhai; Grainne S Gorman; Laura Sutton; Joanna L Elson; Thomas Plötz; Douglass M Turnbull; Michael I Trenell
Journal:  PLoS One       Date:  2011-07-22       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.